Provided By GlobeNewswire
Last update: Nov 4, 2024
BOSTON and LONDON, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its management team will participate in the following investor conferences:
Read more at globenewswire.comNASDAQ:CNTA (4/28/2025, 11:52:54 AM)
13.85
+0.06 (+0.44%)
Find more stocks in the Stock Screener